SCHEMBL4472168

SCHEMBL4472168

COc1cc(-c2cnc(N)c3c(-c4ccc5[nH]ccc5c4)csc23)cc(OC)c1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHB4 P54760 6/20 0.72
MAP3K11 Q16584 2/20 0.52
LRRK2 Q5S007 1/20 0.52
EGFR P00533 2/20 0.49
FYN P06241 2/20 0.47
AURKA O14965 1/20 0.47
DYRK3 O43781 1/20 0.47
ROCK2 O75116 1/20 0.47
PRKD3 O94806 1/20 0.47
MAP4K4 O95819 1/20 0.47
ABL1 P00519 1/20 0.47
INSR P06213 1/20 0.47
CSF1R P07333 1/20 0.47
LYN P07948 1/20 0.47
KIT P10721 1/20 0.47
FGFR1 P11362 1/20 0.47
FLT1 P17948 1/20 0.47
FGFR3 P22607 1/20 0.47
AXL P30530 1/20 0.47
FLT4 P35916 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4475736 0.84 EPHB4 (1.00) EPHB4FYNKDRBTK
SCHEMBL3530692 0.84 KDR (0.50) EPHB4MAP3K11LRRK2EGFRFYN
SCHEMBL3530589 0.84 KDR (0.50) EPHB4MAP3K11LRRK2EGFRFYN
SCHEMBL4471359 0.81 EPHB4 (1.00) EPHB4LRRK2FYNAURKAROCK2
SCHEMBL4467196 0.81 EPHB4 (1.00) EPHB4FYNKDRAURKBBTK
SCHEMBL3527962 0.79 EPHB4 (0.52) EPHB4EGFRFYNAURKADYRK3
SCHEMBL4473618 0.78 EPHB4 (1.00) EPHB4FYNKDR
SCHEMBL4489673 0.78 EPHB4 (0.68) EPHB4EGFRFYNAURKADYRK3
SCHEMBL4469106 0.78 EPHB4 (0.76) EPHB4FYNKDR
SCHEMBL4461250 0.78 EPHB4 (0.70) EPHB4FYNPRKD3MAP4K4CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US claimed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US claimed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-7592352-B2 Substituted thieno and furo-pyridines SMITHKLINE BEECHAM CORPORATION (US) 2009-09-22 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed
US-20080182868-A1 Novel chemical compounds SMITHKLINE BEECHAM CORPORATION 2008-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182868-A1 Novel chemical compounds HRAS, VHL, TP53 EPHB4 2484/4885MAP3K11 19/4885LRRK2 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.